Market research

EUCR Eucrates Biomedical Acquisition Corp.

NASDAQ USD Financial Services

Latest close

— —

Loading market data…

Test a moving-average rule with historical data.

Market facts

Market cap: 42M
P/E ratio: 47.81
Analyst target: Not available
Dividend yield: 0.0%
Beta: -0.07

Loading price history…

Profile

Company facts

Exchange: NASDAQ
Currency: USD
Sector: Financial Services
Industry: Shell Companies
ISIN: VGG3141W1068
Market cap: 42M
P/E ratio: 47.81
Analyst target: Not available
Dividend yield: 0.0%
Beta: -0.07

About

About Eucrates Biomedical Acquisition Corp.

Eucrates Biomedical Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It focuses to identify and acquire a business in the biomedical or healthcare-related industries in North America and Europe. The company was incorporated in 2020 and is based in New York, New York.

Reported results

Fundamentals

Open this section to load reported financial history.

Annual returns

No comments yet

Start a focused discussion about EUCR.

EUCR Eucrates Biomedical Acquisition Corp.

Price & volume

Company facts

About Eucrates Biomedical Acquisition Corp.

Fundamentals

Earnings

Cash flow

Profitability

Valuation

Performance

Annual returns

Investor discussion

No comments yet